Yan Han

Yan Han

Auto-generated profile, based on publicly available information

Yan Han

Department of Pathology, Quanzhou First Hospital Affiliated to Fujian Medical University, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2024 in Hematological Oncology
Verified
Journal Article
Open access
YHYan Han
Yan Han
CLChuntuan Li
Chuntuan Li
SLShengquan Liu
Shengquan Liu
JGJingjing Gao
Jingjing Gao
YHYanjun He
Yanjun He
XZXiongpeng Zhu
Xiongpeng Zhu
Mantle cell lymphoma (MCL) is a rare and aggressive form of non‐Hodgkin lymphoma. Challenges in its treatment include relapse, drug resistance, and a short survival period. The Hedgehog/GLI1 (Hh/GLI1) and Wnt/β‐catenin pathways are crucial in cancer cell proliferation, survival, and drug resistance, making them significant targets for anticancer research. This study aimed to assess the effectiveness of combining inhibitors for both pathways against MCL and investigate the underlying molecular mechanisms. The co‐expression of key proteins from the Hh/GLI1 and Wnt/β‐catenin pathways was observed in MCL. Targeting the Hh/GLI1 pathway with the GLI1 inhibitor GANT61 and the Wnt/β‐catenin pathway with the CBP/β‐catenin transcription inhibitor ICG‐001, dual‐target therapy was demonstrated to synergistically suppressed the activity of MCL cells. This approach promoted MCL cell apoptosis, induced G0/G1 phase blockade, decreased the percentage of S‐phase cells, and enhanced the sensitivity of MCL cells to the drugs adriamycin and ibrutinib. Both GANT61 and ICG‐001 downregulated GLI1 and β‐catenin while upregulating GSK‐3β expression. The interaction between Hh/GLI1 and Wnt/β‐catenin pathways was mediated by GANT61‐dependent Hh/GLI1 inhibition. Moreover, GLI1 knockdown combined with ICG‐001 synergistically induced apoptosis and increased drug sensitivity of MCL cells to doxorubicin and ibrutinib. GANT61 attenuated the overexpression of β‐catenin and decreased the inhibition of GSK‐3β in MCL cells. Overall, the combined targeting of both the Hh/GLI1 and Wnt/β‐catenin pathways was more effective in suppressing proliferation, inducing G0/G1 cycle retardation, promoting apoptosis, and increasing drug sensitivity of MCL cells than mono treatments. These findings emphasize the potential of combinatorial therapy for treating MCL patients.

25 February 2026 in Journal of International Medical Research
Verified
Journal Article
Open access
YHYan Han
Yan Han
JYJinling Yang
Jinling Yang
HWHailong Wang
Hailong Wang
YXYuru Xu
Yuru Xu
WWWeiqi Wu
Weiqi Wu
YCYifeng CHEN
Yifeng CHEN
Purpose: To investigate the association between Syndecan-2 gene methylation and protein expression dynamics in colorectal cancer and evaluate its clinicopathological significance. Methods: We analyzed 197 tissues (96 colorectal cancer, 64 adenoma, and 37 normal tissues). Syndecan-2 methylation was quantified using quantitative methylation-specific polymerase chain reaction, and protein expression was evaluated via immunohistochemistry. Results: Syndecan-2 methylation frequency was significantly higher in colorectal cancer (81.25%) and adenoma (64.06%) than in normal (5.41%) tissues. It showed high diagnostic accuracy for colorectal cancer (area under the curve = 0.88). Although methylation status was unrelated to most clinical parameters, higher methylation levels were correlated with poor tumor differentiation ( p  =   0.022). Syndecan-2 protein was aberrantly expressed in tumor stroma but lacked clinical correlations. A significant positive correlation between methylation and protein expression was observed across the sample ( p  < 0.05); however, this association was not maintained within the colorectal cancer subgroup specifically, showing no intrasample concordance (Kappa statistic = −0.046). Conclusion: Syndecan-2 methylation serves as a highly sensitive epigenetic biomarker for the early detection of colorectal cancer. The findings reveal a complex and heterogeneous relationship between Syndecan-2 methylation and its protein expression during colorectal cancer progression, suggesting stage-specific regulatory mechanisms. Further multiomics studies are warranted to elucidate the underlying functional dynamics.

16 June 2023
Verified
Conference Paper
Closed access
PDF file
LWLiang Wang
Liang Wang
HYHan Yan
Han Yan
In order to solve the problems of winches in fully mechanized coal mining face used to do the roadway supports withdrawal work, such as the difficult operation, the tedious positioning, the inefficiency, the frequent pull-off and rope breakage and so on. A new dual-speed multi-purpose withdrawal winch with variable frequency speed control and self-supporting positioning system is proposed in this paper. Firstly, The shape and performance boundary parameters of the new winch are obtained by analyzing and investigating the existing winches and the requirements of the new. Secondly, the transmission system is designed including the calculation of drum, the development of variable frequency motor with low speed and high torque and the design and arrangement of reducer. Then the overall structure of the new dual-speed multi-purpose winch is designed by combining the researches mentioned above and the development of the optional support device. Finally, from the application effect of the new winch, the design scheme of overall structure is reasonable, reliable and fully meets the actual demands.